CompanyGraph
Builds precision instruments that combine three sensor types to produce measurements accurate enough to anchor FDA and FAA certifications.
- Depends onDownstream position: depends on 12 industries, supplies 4
- ScaleMarket cap is higher than 95% of all stocks globally
- FinancialsAltman Z-Score: safe zone
- Interpretations8 currently firing — 2 · 1 · 5
What this company is and how it runs — written from structure, not news.
Ametek builds instruments that combine optical, piezoelectric, and electromagnetic sensors into a single device, where all three take readings simultaneously and the instrument flags any disagreement between them rather than smoothing it out — producing the micrometre and parts-per-million accuracy that ophthalmologists, aircraft manufacturers, and refineries need but that no single sensor type can deliver alone. Because regulators write customers' FDA and RTCA DO-160 approvals against this specific cross-validated output, the instrument's calibration protocol becomes a load-bearing piece of the customer's own certification — so switching to a competitor means rerunning that certification from scratch, which takes years in medical devices and 18 to 24 months in aerospace. Every instrument must also be assembled and calibrated inside Ametek's Pennsylvania facility, where controlled conditions keep sensor alignment within the tolerances the fusion algorithm assumes, meaning the manufacturing cannot simply be moved or contracted out without producing readings that are internally consistent but systematically wrong. The whole structure depends on the engineers at that Pennsylvania facility who know, for each application domain, exactly what disagreement between the three sensors looks like under real operating conditions — if that group disperses, the cross-validation logic becomes an artifact no one can extend, and the pin holding customers' certifications in place is gone.
How does this company make money?
The company earns money each time it sells a precision instrument. It then collects recurring revenue from the same customers over many years — selling replacement sensors as components wear, performing calibration services required to keep measurements within certified tolerances, and providing software updates that maintain measurement accuracy as the instrument ages.
What makes this company hard to replace?
An ophthalmologist who wants to switch to a different instrument supplier faces a multi-year FDA revalidation process before the new instrument can be used in diagnosis. An aircraft manufacturer faces 18 to 24 months of RTCA DO-160 recertification to transfer to a different sensor supplier. Industrial customers have the company's calibration protocols embedded directly into their manufacturing lines, and switching means completely requalifying those lines. In each case, the customer's own regulatory approval is what is at stake, making switching costly in time rather than just money.
What limits this company?
Every instrument must be assembled and calibrated inside the Pennsylvania facility. Contamination or vibration during manufacturing shifts the sensors just enough that the cross-checking algorithm produces readings that look correct but are systematically wrong. No software fix can compensate for a physically misaligned sensor — so the factory floor in Pennsylvania is the hard ceiling on how many instruments can be built.
What does this company depend on?
The company cannot operate without piezoelectric crystal suppliers for sensor transduction, precision optical glass from specialized manufacturers, semiconductor fabrication facilities for the custom sensor chips, FDA approval for its medical diagnostic instruments, and RTCA DO-160 aerospace certification for its flight-critical components.
Who depends on this company?
Ophthalmologists rely on the company's instruments for eye measurements accurate enough to support diagnoses — without them, that diagnostic accuracy degrades. Commercial aircraft manufacturers depend on the aerospace sensors to keep flight control systems certified — losing them means losing that certification. Petroleum refineries use the gas monitoring instruments to stay within safety thresholds during chemical processing — without them, real-time monitoring fails.
How does this company scale?
Once the sensor fusion algorithms and calibration software are developed for a specific measurement problem, they can be applied across additional products in that same domain without being rebuilt from scratch. What does not scale automatically is the custom engineering work needed for each new niche application — that requires specialists who understand both the underlying measurement science and the exact conditions the instrument will face in the customer's environment.
What external forces can significantly affect this company?
Changes to FDA rules can stretch how long it takes to get ophthalmic diagnostic instruments approved, slowing the medical product line. If the FAA raises its certification standards, aerospace sensor components may need to be retested and reapproved at additional cost. European Union REACH chemical regulations can restrict the materials the company is allowed to use in its industrial monitoring instruments, which could force redesigns.
Where is this company structurally vulnerable?
If the sensor fusion engineers at the Pennsylvania facility — the people who know how disagreement patterns between the optical, piezoelectric, and electromagnetic sensors map to real measurement errors in each application — left or were lost, no amount of spending could quickly reconstruct that knowledge. The cross-validation logic would become a black box that no one could update or recertify against new hardware, and the mechanism that ties customers' regulatory approvals to this instrument would dissolve.
Price is read as structure — trend, levels, range, peak and volatility drawn on the chart. It does not predict where price goes next.
Sign in to view price data.
Sign in2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock behaving?
Multi-Year Up-Close-Week Share With Profitability And Book-Value Growth
Three observations describe the present configuration: a high share of the trailing three years' weekly closes were higher than the prior week, the company has reported positive net income in each of the last five annual periods, and the book-value-increase-consistency composite over the trailing 5 years is elevated.
Close In Upper Portion Of Recent Range, Bollinger Bands, And RSI
Current close sits in the upper portion of the 14-week high-low range; current close sits in the upper portion of its 20-week Bollinger Bands; RSI sits above its 20-week recent mean (Bollinger %B applied to RSI).
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
What the company actually pays, and whether its own cash supports it.
Screen for this company's dividend patterns
Find other companies where the same dividend readings fire.
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company return capital?
Long Dividend Streak With FCF Coverage
Three observations co-occur: a long uninterrupted dividend streak with growth, FCF-based dividend coverage and payment stability, and industry-benchmarked FCF/OCF conversion in its elevated range. All three read a multi-year history, so together they describe a record of dividend payment backed by free cash flow, not a reading of the company today.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
The reported statements, read against the company's own industry.
5 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Goodwill-Heavy Equity
Equity position looks solid, but the composition deserves a look. Equity ratio is elevated for its industry while goodwill is a large share of total assets and large relative to shareholders equity. The equity cushion sits substantially on acquisition-premium book value rather than on retained earnings or paid-in capital.
How does this company use capital?
Rising Operating Income With Low Depreciation on a Capital-Heavy Balance Sheet
Three observations describe a low-D&A profile alongside rising operating income: operating income has increased year-over-year across the trailing four years, EBIT is close to EBITDA in the most recent period (small D&A), and non-current assets are a large share of total assets. The composition is consistent with under-depreciation or a young asset base whose depreciation has not yet caught up.
FCF Ratios Elevated
Three FCF-denominator ratios co-occur in their elevated ranges: FCF/total assets, FCF/total shareholders' equity, and industry-benchmarked FCF/OCF. The configuration describes free cash flow scaling against three different denominators at the latest annual snapshot.
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Three multi-year observations co-occur: revenue increased year-over-year in each of the last three fiscal years, gross profit (absolute level) increased year-over-year in each of the last four fiscal years, and net income was positive in each of the last five fiscal years. The configuration describes growth-and-profitability persistence across three different windows.
How is this stock valued?
High Retained Earnings With Profitability And Equity
Retained earnings are a large share of total assets; net income was positive in each of the last 5 fiscal years; shareholders' equity is in the upper part of its industry's equity-to-assets range.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Supply Chain
Scale
Companies that share the same coordination system — how they create, deliver, or capture value.
Companies that share active interpretations — structural patterns currently present in both stocks.